NICE welcomes five new Non-Executive Directors to its board
Five new Non-Executive Directors have been appointed to the Board of NICE
NICE welcomes landmark fall in antibiotic prescriptions
Fewer antibiotics are being prescribed by doctors in England for the first time, new data shows.
Price discount helps give green light for breast cancer drug pertuzumab
NICE approves the third breast cancer drug is as many weeks as pertuzumab is recommended to shrink tumours in some people with breast cancer so surgery can take place.
NICE approves three quarters of CDF group 1 drugs for routine use
More than 75% of treatments in the Cancer Drugs Fund (CDF) which have been looked at again by NICE have received positive recommendations for routine NHS use.
Latest news headlines
-
NICE says pancreatic cancer treatment considered not cost effective for routine NHS use
The drug pegylated liposomal irinotecan, was not clinically effective enough to justify its high cost, NICE says in draft guidance.
15 November 2016
-
Price cuts pave the way for routine access to breast and lung cancer drugs
People with breast cancer and lung cancer will have routine access to two life-extending treatments after the makers agreed to reduce their prices to make them cost effective.
10 November 2016
-
Life-extending breast cancer drug approved by NICE in draft guidance
People with advanced breast cancer are set to benefit from a life-extending drug as NICE says it should be available on the NHS.
03 November 2016
-
People in prison should receive the same level of care as those outside, says NICE
New guidance from NICE will ensure that people in prison receive the same standard of healthcare as those in society.
02 November 2016
-
Head and neck cancer drug is not cost-effective
Cetuximab is not value for money says NICE in new draft guidance
01 November 2016
-
NICE recommends wider use of tests to detect cancer-causing genetic condition
In draft guidance published today for consultation NICE has recommended that everyone who is diagnosed with colorectal cancer should be tested for an inherited genetic condition called Lynch syndrome (LS).
21 October 2016